Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP
Clinical trial NCT05308472 · COMPLETED
Trial details
- NCT number
- NCT05308472
- Sponsor
- Disc Medicine, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2024-02-20
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.